## CHD: Church & Dwight Company, Inc. - XLP: Consumer Defensive

### Executive Summary

No thesis match: MRS_20 -2.2% below STRENGTH zone (4.0-10.0%); PEG 1.88 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($80.21)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Church & Dwight to sell VitaFusion and L’il Critters brands to Piping Rock By Investing.com**
- Source: Investing.com South Africa | 20251209T222158 | Somewhat-Bullish | Relevance: 100%
- Church & Dwight Co., Inc. (NYSE:CHD) has announced a definitive agreement to sell its VitaFusion and L’il Critters vitamin brands to Piping Rock Health Products, Inc. This strategic move, expected to close by the end of 2025, follows a review of Church & Dwight’s vitamin business, which represents less than 5% of its anticipated 2025 net sales. The company expects to incur a one-time, after-tax charge of $40 million to $45 million in the fourth quarter of 2025 related to the transaction.

**2. Church & Dwight to sell VitaFusion and L’il Critters brands to Piping Rock**
- Source: Investing.com | 20251209T220911 | Somewhat-Bullish | Relevance: 99%
-  Church & Dwight Co., Inc. (NYSE:CHD) announced the sale of its VitaFusion and L’il Critters vitamin brands to Piping Rock Health Products, Inc. This transaction, expected to close before the end of 2025, follows a strategic review of Church & Dwight's vitamin, minerals, and supplement business, which represents less than 5% of their anticipated 2025 net sales. The company expects an after-tax charge of $40 million to $45 million in Q4 2025 related to the deal.

**3. How Is Church & Dwight's Stock Performance Compared to Other Consumer Staples Stocks?**
- Source: inkl | 20251209T090759 | Neutral | Relevance: 99%
- Church & Dwight (CHD) stock has underperformed significantly compared to the broader Consumer Staples Select Sector SPDR Fund (XLP) over the past three months, year-to-date, and the last 52 weeks. Despite a post-Q3 earnings surge due to better-than-expected results, the stock reflects a bearish trend, trading below its moving averages. Analysts, however, rate CHD as a "Moderate Buy" with a substantial upside potential.

**4. Church & Dwight to sell vitamin gummy businesses (CHD:NYSE)**
- Source: Seeking Alpha | 20251210T150750 | Neutral | Relevance: 99%
-  Church & Dwight (CHD) is divesting its vitamin gummy businesses, including VitaFusion and L’il Critters, following a strategic review of its vitamin, mineral, and supplement segments. These businesses collectively represent less than 5% of Church & Dwight’s overall operations.

**5. Church & Dwight (NYSE: CHD) to divest VitaFusion and L’il Critters VMS brands**
- Source: Stock Titan | 20251209T214734 | Neutral | Relevance: 99%
-  Church & Dwight Co., Inc. (NYSE: CHD) has entered into a definitive agreement to sell its VitaFusion® and L’il Critters® brands. This divestiture follows a strategic review of the company's vitamins, minerals and supplements (VMS) business and includes related trademarks, licenses, and manufacturing/distribution facilities in Vancouver and Ridgefield, Washington. The transaction is expected to close before year-end, subject to customary closing conditions.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 2)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-10 | Deutsche Bank | $100 | $102 | -2% |
| 2025-12-04 | Argus Research | $102 | $110 | -7% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-10 | Deutsche Bank | main | Buy |
| 2025-12-04 | Argus Research | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 18 ($0.04M) |
| Sells | 0 ($0.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 48.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.0% (-2.1%)
- Blackrock Inc.: 9.3% (-1.1%)
- State Street Corpora: 5.7% (+2.4%)
- JPMORGAN CHASE & CO: 5.1% (+105.9%)
- Capital Internationa: 4.0% (+0.5%)

### Key Risks

1. Long-term trend broken: trading 12.0% below SMA200.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 1.88 elevated, pricing in significant growth expectations. Forward P/E 22.3x stretched relative to 7% growth. Analyst sentiment negative (2 target cuts vs 0 raises). Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $20.4B |
| Beta | 0.45 |
| 52W Range | $81.33 - $116.46 |
| Short Interest | 4.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.88 |
| Forward P/E | 22.3 |
| Current P/E | 23.9 |
| YoY Growth | 7.4% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -2.2% (minimal 5-day change). Below STRENGTH zone by 6.2pp (needs >4.0% for momentum thesis). MRS_5 turning positive (0.5%) - potential reversal signal. Below SMA200 (0.88x), long-term trend not supportive. RSI neutral at 47. Elevated volume (1.3x 20MA), institutional activity likely.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -2.23% (CS: 28) | Weak |
| RSI_14 | 46.9 | Neutral |
| MACD Histogram | 0.05 | Bullish |
| vs SMA20 | 0.999x | Below |
| vs SMA50 | 0.978x | Below |
| vs SMA200 | 0.880x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $83.57
- **Stop Loss:** $80.21 (4.0% risk)
- **Target:** $86.93 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 410
- **Position Value:** $34,263.70
- **Portfolio %:** 34.26%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-01-30 (Est: $0.84)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.74 | $0.81 | +9.9% |
| 2025Q2 | $0.86 | $0.94 | +9.5% |
| 2025Q1 | $0.90 | $0.91 | +1.4% |
| 2024Q4 | $0.77 | $0.77 | +0.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*